JPRN-UMIN000008947已完成2 期
Phase II study of bevacizumab and irinotecan plus alternate-day S-1 as second-line therapy in patients with metastatic colorectal cancer. - AIRS study
Epidemiological and Clinical research Information Network (ECRIN)0 个研究点目标入组 40 人开始时间: 2012年9月19日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)History of serious drug hypersensitivity 2)Active infections 3) Serious complications (interstitial pneumonitis, pulmonary fibrosis, renal failure, liver dysfunction, poorly controlled DM, poorly controlled hypertension) 4) Distinctly abnormal ECG or cardiovascular disease (heart failure, myocardial infarction, angina) 5) Massive pleural effusion or ascites 6) Ongoing treatment with Flucytosine, Phenytoin or Warfarin potassium 7) Synchronous or metachronous malignancy except carcinoma in situ 8) Prior radiotherapy 9) Diarrhea 10) Active hepatitis type HBs positive 11) History of thromboembolism, brain infarction, pulmonary infarction and interstitial pneumonitis 12) GI perforation or hemorrhage 13) Peritoneal metastasis 14) Brain metastasis 15)Pregnant or possibly pregnant women 16) Men who want get partner pregnant. 17) Other conditions not suitable for this study
研究者
相似试验
已完成
2 期
Phase II study of bevacizumab and irinotecan as second-line therapy in patients with metastatic colorectal cancer previously treated with fluoropyrimidine, oxaliplatin, and bevacizumabJPRN-UMIN000005228Tokyo Women's Medical University33
招募中
不适用
Phase 2 study of bevacizumab and irinotecan as second-line therapy in patients with advanced colorectal cancer previously treated with oxaliplatin and bavacizumabadvanced colorectal cancerJPRN-UMIN000007065Toyama Prefectural Central Hospital Department of Gastroenterology33
进行中（未招募）
1 期
A phase II trial with bevacizumab and irinotecan for patients withprimary brain tumors and progression after standard therapy - BI-Brain-01Primary malignant brain tumorsEUCTR2006-006011-74-DKRigshospitalet
已完成
2 期
A phaseII study of irinotecan with bevacizumab as third line treatment for patients with metastatic colorectal cancer after failure to irinotecan who have progressed on bevacizumab with oxaliplatin-based chemotherapy in second line.colorectal cancerJPRN-UMIN000009910Tsuchiura kyodo general hospital25
已完成
1 期
A phaseI/II study of irinotecan with bevacizumab as second line treatment of elderly patients with metastatic colorectal cancer.colorectal cancerJPRN-UMIN000009911Tsuchiura kyodo general hospital25